chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Eye pain, Movement disorder, Musculoskeletal stiffness, Myalgia
Clinical narrative: all of his bones in his body was aching; stated that he could hardly move; his eyes were hurting like his pressure was up; muscle pain; stiffness of muscles; eyes are hurting; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Lot number: EN6205, Expiration Date: 30Jun2021) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Back issues", start date: 1985 (ongoing). The patient's concomitant medications were not reported. The following information was reported: MYALGIA (non-serious) with onset Mar2021, outcome "unknown", described as "muscle pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset Mar2021, outcome "unknown", described as "stiffness of muscles"; EYE PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "eyes are hurting"; BONE PAIN (non-serious) with onset 12Mar2021, outcome "not recovered", described as "all of his bones in his body was aching"; MOVEMENT DISORDER (non-serious) with onset 12Mar2021, outcome "not recovered", described as "stated that he could hardly move"; OCULAR DISCOMFORT (non-serious) with onset 12Mar2021, outcome "not recovered", described as "his eyes were hurting like his pressure was up". Therapeutic measures were taken as a result of eye pain, ocular discomfort.  Additional Information: It was reported that 10 days later, He experienced muscle pain, stiffness of muscles, eyes are hurting - He wants to know if these symptoms are normal. Treatment: Stated that he put a heating pad on and used eye drops.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Ocular discomfort
Clinical narrative: all of his bones in his body was aching; stated that he could hardly move; his eyes were hurting like his pressure was up; muscle pain; stiffness of muscles; eyes are hurting; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Lot number: EN6205, Expiration Date: 30Jun2021) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Back issues", start date: 1985 (ongoing). The patient's concomitant medications were not reported. The following information was reported: MYALGIA (non-serious) with onset Mar2021, outcome "unknown", described as "muscle pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset Mar2021, outcome "unknown", described as "stiffness of muscles"; EYE PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "eyes are hurting"; BONE PAIN (non-serious) with onset 12Mar2021, outcome "not recovered", described as "all of his bones in his body was aching"; MOVEMENT DISORDER (non-serious) with onset 12Mar2021, outcome "not recovered", described as "stated that he could hardly move"; OCULAR DISCOMFORT (non-serious) with onset 12Mar2021, outcome "not recovered", described as "his eyes were hurting like his pressure was up". Therapeutic measures were taken as a result of eye pain, ocular discomfort.  Additional Information: It was reported that 10 days later, He experienced muscle pain, stiffness of muscles, eyes are hurting - He wants to know if these symptoms are normal. Treatment: Stated that he put a heating pad on and used eye drops.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Decreased appetite, Depression, Dysgeusia, Dyspepsia
Clinical narrative: Ulcers in her mouth; Ocular migraine; headache; Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side; Smell smoke; heavy and sore arm; Wide awake; metallic taste; Indigestion,Heartburn; Anxious; No appetite; Abdominal pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021330170 (Pfizer).  A 72 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Feb2021 14:15 (Lot number: EN9581) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "seasonal allergies" (ongoing), notes: Verbatim: seasonal allergies; "Asthma" (ongoing), notes: Verbatim: Asthma; "Reflux" (unspecified if ongoing); "Bronchiectasis" (unspecified if ongoing); "Hypogammaglobulinemia" (unspecified if ongoing); "BP Irregularity" (unspecified if ongoing); "Known allergies; dust" (unspecified if ongoing); "calcification around the vessel of the heart" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal; ZOCOR taken for blood cholesterol abnormal; PULMICORT taken for asthma; PROTONIX [OMEPRAZOLE]. The following information was reported: HEADACHE (non-serious) with onset 06Feb2021, outcome "unknown", described as "headache"; DYSGEUSIA (non-serious) with onset 2021, outcome "unknown", described as "metallic taste"; PAIN (non-serious) with onset 06Feb2021, outcome "not recovered", described as "Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side"; INSOMNIA (non-serious) with onset 05Feb2021, outcome "unknown", described as "Wide awake"; PAROSMIA (non-serious) with onset 06Feb2021, outcome "unknown", described as "Smell smoke"; MOUTH ULCERATION (non-serious) with onset 10Feb2021, outcome "unknown", described as "Ulcers in her mouth"; OPHTHALMIC MIGRAINE (non-serious) with onset 09Feb2021, outcome "unknown", described as "Ocular migraine"; DYSPEPSIA (non-serious) with onset 2021, outcome "unknown", described as "Indigestion,Heartburn"; DEPRESSION (non-serious) with onset 2021, outcome "unknown", described as "Anxious"; DECREASED APPETITE (non-serious) with onset 2021, outcome "unknown", described as "No appetite"; PAIN IN EXTREMITY (non-serious) with onset 05Feb2021, outcome "unknown", described as "heavy and sore arm"; ABDOMINAL PAIN (non-serious) with onset 2021, outcome "unknown", described as "Abdominal pain".  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Insomnia, Mouth ulceration, Ophthalmic migraine, Pain
Clinical narrative: Ulcers in her mouth; Ocular migraine; headache; Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side; Smell smoke; heavy and sore arm; Wide awake; metallic taste; Indigestion,Heartburn; Anxious; No appetite; Abdominal pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021330170 (Pfizer).  A 72 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Feb2021 14:15 (Lot number: EN9581) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "seasonal allergies" (ongoing), notes: Verbatim: seasonal allergies; "Asthma" (ongoing), notes: Verbatim: Asthma; "Reflux" (unspecified if ongoing); "Bronchiectasis" (unspecified if ongoing); "Hypogammaglobulinemia" (unspecified if ongoing); "BP Irregularity" (unspecified if ongoing); "Known allergies; dust" (unspecified if ongoing); "calcification around the vessel of the heart" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal; ZOCOR taken for blood cholesterol abnormal; PULMICORT taken for asthma; PROTONIX [OMEPRAZOLE]. The following information was reported: HEADACHE (non-serious) with onset 06Feb2021, outcome "unknown", described as "headache"; DYSGEUSIA (non-serious) with onset 2021, outcome "unknown", described as "metallic taste"; PAIN (non-serious) with onset 06Feb2021, outcome "not recovered", described as "Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side"; INSOMNIA (non-serious) with onset 05Feb2021, outcome "unknown", described as "Wide awake"; PAROSMIA (non-serious) with onset 06Feb2021, outcome "unknown", described as "Smell smoke"; MOUTH ULCERATION (non-serious) with onset 10Feb2021, outcome "unknown", described as "Ulcers in her mouth"; OPHTHALMIC MIGRAINE (non-serious) with onset 09Feb2021, outcome "unknown", described as "Ocular migraine"; DYSPEPSIA (non-serious) with onset 2021, outcome "unknown", described as "Indigestion,Heartburn"; DEPRESSION (non-serious) with onset 2021, outcome "unknown", described as "Anxious"; DECREASED APPETITE (non-serious) with onset 2021, outcome "unknown", described as "No appetite"; PAIN IN EXTREMITY (non-serious) with onset 05Feb2021, outcome "unknown", described as "heavy and sore arm"; ABDOMINAL PAIN (non-serious) with onset 2021, outcome "unknown", described as "Abdominal pain".  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Parosmia
Clinical narrative: Ulcers in her mouth; Ocular migraine; headache; Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side; Smell smoke; heavy and sore arm; Wide awake; metallic taste; Indigestion,Heartburn; Anxious; No appetite; Abdominal pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021330170 (Pfizer).  A 72 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Feb2021 14:15 (Lot number: EN9581) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "seasonal allergies" (ongoing), notes: Verbatim: seasonal allergies; "Asthma" (ongoing), notes: Verbatim: Asthma; "Reflux" (unspecified if ongoing); "Bronchiectasis" (unspecified if ongoing); "Hypogammaglobulinemia" (unspecified if ongoing); "BP Irregularity" (unspecified if ongoing); "Known allergies; dust" (unspecified if ongoing); "calcification around the vessel of the heart" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal; ZOCOR taken for blood cholesterol abnormal; PULMICORT taken for asthma; PROTONIX [OMEPRAZOLE]. The following information was reported: HEADACHE (non-serious) with onset 06Feb2021, outcome "unknown", described as "headache"; DYSGEUSIA (non-serious) with onset 2021, outcome "unknown", described as "metallic taste"; PAIN (non-serious) with onset 06Feb2021, outcome "not recovered", described as "Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side"; INSOMNIA (non-serious) with onset 05Feb2021, outcome "unknown", described as "Wide awake"; PAROSMIA (non-serious) with onset 06Feb2021, outcome "unknown", described as "Smell smoke"; MOUTH ULCERATION (non-serious) with onset 10Feb2021, outcome "unknown", described as "Ulcers in her mouth"; OPHTHALMIC MIGRAINE (non-serious) with onset 09Feb2021, outcome "unknown", described as "Ocular migraine"; DYSPEPSIA (non-serious) with onset 2021, outcome "unknown", described as "Indigestion,Heartburn"; DEPRESSION (non-serious) with onset 2021, outcome "unknown", described as "Anxious"; DECREASED APPETITE (non-serious) with onset 2021, outcome "unknown", described as "No appetite"; PAIN IN EXTREMITY (non-serious) with onset 05Feb2021, outcome "unknown", described as "heavy and sore arm"; ABDOMINAL PAIN (non-serious) with onset 2021, outcome "unknown", described as "Abdominal pain".  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Breast pain, Dysgeusia, Gastric disorder, Headache
Clinical narrative: Ulcers in her mouth; Ocular migraine; headache; Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side; Smell smoke; heavy and sore arm; Wide awake; metallic taste; Indigestion,Heartburn; Anxious; No appetite; Abdominal pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021330170 (Pfizer).  A 72 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Feb2021 14:15 (Lot number: EN9581) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "seasonal allergies" (ongoing), notes: Verbatim: seasonal allergies; "Asthma" (ongoing), notes: Verbatim: Asthma; "Reflux" (unspecified if ongoing); "Bronchiectasis" (unspecified if ongoing); "Hypogammaglobulinemia" (unspecified if ongoing); "BP Irregularity" (unspecified if ongoing); "Known allergies; dust" (unspecified if ongoing); "calcification around the vessel of the heart" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal; ZOCOR taken for blood cholesterol abnormal; PULMICORT taken for asthma; PROTONIX [OMEPRAZOLE]. The following information was reported: HEADACHE (non-serious) with onset 06Feb2021, outcome "unknown", described as "headache"; DYSGEUSIA (non-serious) with onset 2021, outcome "unknown", described as "metallic taste"; PAIN (non-serious) with onset 06Feb2021, outcome "not recovered", described as "Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side"; INSOMNIA (non-serious) with onset 05Feb2021, outcome "unknown", described as "Wide awake"; PAROSMIA (non-serious) with onset 06Feb2021, outcome "unknown", described as "Smell smoke"; MOUTH ULCERATION (non-serious) with onset 10Feb2021, outcome "unknown", described as "Ulcers in her mouth"; OPHTHALMIC MIGRAINE (non-serious) with onset 09Feb2021, outcome "unknown", described as "Ocular migraine"; DYSPEPSIA (non-serious) with onset 2021, outcome "unknown", described as "Indigestion,Heartburn"; DEPRESSION (non-serious) with onset 2021, outcome "unknown", described as "Anxious"; DECREASED APPETITE (non-serious) with onset 2021, outcome "unknown", described as "No appetite"; PAIN IN EXTREMITY (non-serious) with onset 05Feb2021, outcome "unknown", described as "heavy and sore arm"; ABDOMINAL PAIN (non-serious) with onset 2021, outcome "unknown", described as "Abdominal pain".  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Pain, Parosmia
Clinical narrative: Ulcers in her mouth; Ocular migraine; headache; Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side; Smell smoke; heavy and sore arm; Wide awake; metallic taste; Indigestion,Heartburn; Anxious; No appetite; Abdominal pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021330170 (Pfizer).  A 72 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Feb2021 14:15 (Lot number: EN9581) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "seasonal allergies" (ongoing), notes: Verbatim: seasonal allergies; "Asthma" (ongoing), notes: Verbatim: Asthma; "Reflux" (unspecified if ongoing); "Bronchiectasis" (unspecified if ongoing); "Hypogammaglobulinemia" (unspecified if ongoing); "BP Irregularity" (unspecified if ongoing); "Known allergies; dust" (unspecified if ongoing); "calcification around the vessel of the heart" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal; ZOCOR taken for blood cholesterol abnormal; PULMICORT taken for asthma; PROTONIX [OMEPRAZOLE]. The following information was reported: HEADACHE (non-serious) with onset 06Feb2021, outcome "unknown", described as "headache"; DYSGEUSIA (non-serious) with onset 2021, outcome "unknown", described as "metallic taste"; PAIN (non-serious) with onset 06Feb2021, outcome "not recovered", described as "Pain, tingling, numbness in left arm - radiated down into her left leg. Most intense pain in her breasts, especially left side"; INSOMNIA (non-serious) with onset 05Feb2021, outcome "unknown", described as "Wide awake"; PAROSMIA (non-serious) with onset 06Feb2021, outcome "unknown", described as "Smell smoke"; MOUTH ULCERATION (non-serious) with onset 10Feb2021, outcome "unknown", described as "Ulcers in her mouth"; OPHTHALMIC MIGRAINE (non-serious) with onset 09Feb2021, outcome "unknown", described as "Ocular migraine"; DYSPEPSIA (non-serious) with onset 2021, outcome "unknown", described as "Indigestion,Heartburn"; DEPRESSION (non-serious) with onset 2021, outcome "unknown", described as "Anxious"; DECREASED APPETITE (non-serious) with onset 2021, outcome "unknown", described as "No appetite"; PAIN IN EXTREMITY (non-serious) with onset 05Feb2021, outcome "unknown", described as "heavy and sore arm"; ABDOMINAL PAIN (non-serious) with onset 2021, outcome "unknown", described as "Abdominal pain".  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature abnormal, Dehydration, Dry mouth, Fatigue
Clinical narrative: dry mouth; feeling run down/tired; arm hurts; slight runny nose; she felt dehydrated/dehydration; she just took her temperature and it was 96.3 F; insomnia; felt thirsty; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 11Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEHYDRATION (non-serious) with onset 12Mar2021, outcome "unknown", described as "she felt dehydrated/dehydration"; THIRST (non-serious) with onset Mar2021, outcome "unknown", described as "felt thirsty"; DRY MOUTH (non-serious) with onset 12Mar2021, outcome "unknown", described as "dry mouth"; FATIGUE (non-serious) with onset 12Mar2021, outcome "unknown", described as "feeling run down/tired"; PAIN IN EXTREMITY (non-serious) with onset 12Mar2021, outcome "unknown", described as "arm hurts"; RHINORRHOEA (non-serious) with onset 12Mar2021, outcome "unknown", described as "slight runny nose"; INSOMNIA (non-serious) with onset 11Mar2021, outcome "unknown", described as "insomnia"; BODY TEMPERATURE ABNORMAL (non-serious) with onset 12Mar2021, outcome "unknown", described as "she just took her temperature and it was 96.3 F". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: "I did get 1st Pfizer vaccine dose yesterday. Today, I am feeling run down, arm hurts, slight runny nose, dehydration, dry mouth and insomnia last night. I just kept waking up." Patient wanted to know these side effects from the Pfizer vaccine  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain in extremity, Rhinorrhoea, Thirst
Clinical narrative: dry mouth; feeling run down/tired; arm hurts; slight runny nose; she felt dehydrated/dehydration; she just took her temperature and it was 96.3 F; insomnia; felt thirsty; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 11Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEHYDRATION (non-serious) with onset 12Mar2021, outcome "unknown", described as "she felt dehydrated/dehydration"; THIRST (non-serious) with onset Mar2021, outcome "unknown", described as "felt thirsty"; DRY MOUTH (non-serious) with onset 12Mar2021, outcome "unknown", described as "dry mouth"; FATIGUE (non-serious) with onset 12Mar2021, outcome "unknown", described as "feeling run down/tired"; PAIN IN EXTREMITY (non-serious) with onset 12Mar2021, outcome "unknown", described as "arm hurts"; RHINORRHOEA (non-serious) with onset 12Mar2021, outcome "unknown", described as "slight runny nose"; INSOMNIA (non-serious) with onset 11Mar2021, outcome "unknown", described as "insomnia"; BODY TEMPERATURE ABNORMAL (non-serious) with onset 12Mar2021, outcome "unknown", described as "she just took her temperature and it was 96.3 F". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: "I did get 1st Pfizer vaccine dose yesterday. Today, I am feeling run down, arm hurts, slight runny nose, dehydration, dry mouth and insomnia last night. I just kept waking up." Patient wanted to know these side effects from the Pfizer vaccine  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle rigidity, Pain, Vaccination site warmth
Clinical narrative: her arm is really rigid where the injection was given and still warm to touch; her arm is really rigid where the injection was given and still warm to touch; site sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 08:00 (Lot number: EN6201) at the age of 75 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PANTOPRAZOLE taken for gastrooesophageal reflux disease (ongoing). The following information was reported: MUSCLE RIGIDITY (non-serious), VACCINATION SITE WARMTH (non-serious) all with onset 22Feb2021, outcome "not recovered" and all described as "her arm is really rigid where the injection was given and still warm to touch"; PAIN (non-serious) with onset 22Feb2021, outcome "not recovered", described as "site sore".  Additional information: The patient did not require visit to physician or ER as a result of AEs. No Prior Vaccinations (within 4 weeks). No Family History. No Relevant test. The patient stated that the site is still very rigid and warm and feels like a solid muscle. Mentions she called her doctor's office and the nurse called her back and advised to put ice on the site and get the second dose in the other arm. Caller states she is scheduled to receive the second dose on Monday. Caller would like to know if she should receive the second dose.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 51 year-old male patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Batch/Lot number: unknown) at the age of 51 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 02Mar2021, outcome "recovered" (Mar2021), described as "sore arm". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: It was unknown if other vaccine in four weeks or other medications in two weeks. It was unknown if Covid prior to vaccination and if Covid was tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lymph nodes behind her jaw got swollen; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "lymph nodes behind her jaw got swollen".  Additional information: Patient age was reported as 55 (units: unknown). It was reported that, the patient received the 1st dose of the Pfizer covid vaccine on Wednesday night. Her lymph nodes behind her jaw got swollen 2 days later. She is not feeling any other side effects. The patient would like to know how long the side effect of swollen lymph nodes could last. The patient would like to know whether she could get the 2nd dose of the covid vaccine based on her side effects.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Headache, Pain in extremity
Clinical narrative: She's on 2 different antibiotics and caller is wondering if the antibiotics will affect the vaccine; just had a sore arm; mild headache after receiving the vaccine; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 13Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "immunocompromised" (unspecified if ongoing), notes: Caller (retired nurse) stated her daughter is immunocompromised. The patient's concomitant medications were not reported. The following information was reported: CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "She's on 2 different antibiotics and caller is wondering if the antibiotics will affect the vaccine"; PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "just had a sore arm"; HEADACHE (non-serious) with onset Mar2021, outcome "unknown", described as "mild headache after receiving the vaccine".  Additional information. Reporter was reporting for her daughter (patient) received the COVID-19 Vaccine first dose on 13Mar2021.  Reporter was asking if it would be okay to continue her daughter's antibiotic regimen. and mentioned that the last time patient took the antibiotic was on 12Mar2021. Reporter (retired nurse) stated that her daughter was immunocompromised and had the 1st dose of Pfizer's COVID vaccine on 13Mar2021 and she's on 2 different antibiotics. Reporter was wondering if the antibiotics will affect the vaccine, if her daughter can take antibiotics. Reporter also asked if there is any contraindication between the vaccine and the antibiotic.  Follow-up attempts completed. No further information expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: Body aches; mild arm soreness; fatigue; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Mar2021 10:30 (Lot number: EN 6204) at the age of 71 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "AFib" (unspecified if ongoing); "sleep apnea" (unspecified if ongoing); "acid reflux" (unspecified if ongoing); "arthritis" (unspecified if ongoing). Concomitant medication(s) included: ELIQUIS; CELEBREX; CIMETIDINE; LIPITOR [ATORVASTATIN CALCIUM]; NEXIUM [ESOMEPRAZOLE SODIUM]; DILTIAZEM. Vaccination history included: Bnt162b2 (lot_number-EN 6198, vaccine  location-Left arm, administration_time-02:30 PM,, dose_number-1), administration date: 18Feb2021, when the patient was 71 years old, for Covid-19 Vaccination. The following information was reported: PAIN (non-serious) with onset 12Mar2021, outcome "recovered", described as "Body aches"; PAIN IN EXTREMITY (non-serious) with onset 12Mar2021, outcome "recovered", described as "mild arm soreness"; FATIGUE (non-serious) with onset 12Mar2021, outcome "recovered", described as "fatigue". Therapeutic measures were not taken as a result of pain, pain in extremity, fatigue.  Additional information: The patient did not have any allergies. The patient had no other vaccine within four weeks and had other medications received within 2 weeks of vaccination included Eliquis, diltiazem, Celebrex, Lipitor, Cimetidine, Nexium. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling nerves down left side of neck, left shoulder, and arm; This is a spontaneous report received from contactable consumer. The reporter is the patient.  A 78-year-old female patient (not pregnant) received BNT162B2 (BNT162B2) (Batch/Lot number: unknown) at the age of 78 years as dose 1, single and administered in arm left, administration date 19Feb2021 09:30 (Lot number: EN6200) as dose 2, single for COVID-19 immunization. Relevant medical history included: "Malignant hyperthermia" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Succinylcholine, reaction(s): "Allergies". The following information was reported: PARAESTHESIA (non-serious) with onset 03Feb2021, outcome "not recovered", described as "Tingling nerves down left side of neck, left shoulder, and arm". The event "tingling nerves down left side of neck, left shoulder, and arm" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were not taken as a result of paraesthesia.  Additional Information: The patient had no other vaccine in four weeks and no other medications in two weeks. The patient was not diagnosed with COVID-19 prior vaccination. The event increased after second dose on 19Feb2021. The patient has not been tested for COVID-19 post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Experiencing muscle aches arms and legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 11Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunisation. The following information was reported: MYALGIA (non-serious), outcome "unknown", described as "Experiencing muscle aches arms and legs".  Additional information: The patient wanted to know if it was safe to take Tylenol or Ibuprofen after the 2nd dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Product odour abnormal
Clinical narrative: Immediate unusual scent; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN. Past drug history included: Neggram, reaction(s): "Known allergies: NegGram". Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EN6203, lot unknown=False,, administration date=12Mar2021,, administration time=06:15 PM, vaccine location=Left arm, dose number=1), administration date: 12Mar2021, when the patient was 62 years old, for COVID-19 immunisation, reaction(s): "Chest (below throat) began feeling raw/inflamed", "Hot flashes", "My eyes became thicker/puffy", "My nose was completely congested". The following information was reported: PRODUCT ODOUR ABNORMAL (non-serious), outcome "unknown", described as "Immediate unusual scent". Therapeutic measures were not taken as a result of product odour abnormal. Additional information:Covid prior vaccination was no.Covid tested post vaccination was no.other vaccine in four weeks was no.treatment to adverse event was no.Best could correlate the experience to was being in a science class during dissection of a frog and whatever the liquid the frog was pickled in. you smell it and it lasts a while once you leave the classroom.  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Nausea, Vomiting
Clinical narrative: Diarrhea; Nausea; Vomiting; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 12Mar2021 15:45 (Lot number: EN6202) at the age of 22 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LOESTRIN taken for contraception; ALLEGRA; ADVIL [IBUPROFEN]; TYLENOL.  The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "Diarrhea"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; VOMITING (non-serious), outcome "unknown", described as "Vomiting"; CHILLS (non-serious), outcome "unknown", described as "Chills".  Additional Information: The patient had no known allergies.The patient was not pregnant at the time of vaccination. It was reported that the patient did not take any other vaccine in the last four weeks. The patient never had Covid prior vaccination and was not tested for Covid post vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Lethargy, Pain
Clinical narrative: headache; body aches; very lethargic and without much energy 13Mar; very lethargic and without much energy 13Mar/could not do anything except lie down; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Mar2021 09:30 (Lot number: EN6203) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: AMETHYST. Vaccination history included: Bnt162b2 (lot number: EL3247, administration date=19Feb2021,, administration time: 11:30 AM, vaccine location-Left arm, dose number: 1), administration date: 19Feb2021, when the patient was 46 years old, for Covid-19 immunisation. The following information was reported: HEADACHE (non-serious) with onset 13Mar2021, outcome "recovered" (13Mar2021), described as "headache"; PAIN (non-serious) with onset 13Mar2021, outcome "recovered" (14Mar2021), described as "body aches"; LETHARGY (non-serious) with onset 13Mar2021, outcome "recovered" (Mar2021), described as "very lethargic and without much energy 13Mar"; ASTHENIA (non-serious) with onset 13Mar2021, outcome "recovered" (Mar2021), described as "very lethargic and without much energy 13Mar/could not do anything except lie down". Therapeutic measures were not taken as a result of headache, pain, lethargy, asthenia. Additional information: The patient did not receive other vaccine in four weeks. The patient did not have covid prior vaccination and was not tested covid post vaccination. Clinical course: It was reported that patient woke up a little before 2:30 am with a headache and body aches. The headache dissipated once she drank water. The body aches remained until 14Mar2021 late morning. She was very lethargic and without much energy 13Mar2021 and could not do anything except lie down. No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Headache, Malaise, Nausea
Clinical narrative: Headache; Weakness; Nausea; Feeling unwell; Dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 59 year-old male patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) at the age of 59 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Headache"; ASTHENIA (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Weakness"; NAUSEA (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Nausea"; MALAISE (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Feeling unwell"; DIZZINESS (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Dizziness". The action taken for bnt162b2 was unknown. It was unknown if therapeutic measures were taken as a result of headache, asthenia, nausea, malaise, dizziness. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Lethargy, Pain in extremity
Clinical narrative: extremely lethargic; had pains that went down my left arm; sick in bed; a bad headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "recovered", described as "a bad headache"; LETHARGY (non-serious), outcome "recovered", described as "extremely lethargic"; PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "had pains that went down my left arm"; ILLNESS (non-serious), outcome "recovered", described as "sick in bed". Therapeutic measures were taken as a result of headache.  Additional information: After receiving the first shot of Pfizer's COVID vaccine, female consumer had a very mild headache that lasted about 6 hours. "Patient took 2 Tylenol and it went away. Patient had pains that went down to her left arm she had the shot in which were pretty intense but only lasted a second each. Patient was sick in bed the whole next day with a bad headache and was extremely lethargic and she is normally extremely healthy. On the 2nd day, she was back to normal.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Discomfort, Fatigue, Lethargy, Pain in extremity
Clinical narrative: My wife and I stay hydrated either before or at least after our second shot so as to help reduce the impact of any side effects; his wife experienced tiredness; discomfort for several days; sore arms; lethargy; she experienced discomfort for both of her buttock; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (BNT162B2), administration date 27Feb2021 (Batch/Lot number: unknown) as 1st dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "My wife and I stay hydrated either before or at least after our second shot so as to help reduce the impact of any side effects"; FATIGUE (non-serious), outcome "unknown", described as "his wife experienced tiredness"; DISCOMFORT (non-serious), outcome "unknown", described as "discomfort for several days"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arms"; LETHARGY (non-serious), outcome "unknown", described as "lethargy"; PELVIC DISCOMFORT (non-serious), outcome "unknown", described as "she experienced discomfort for both of her buttock".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021285186 same reporter/drug/AE, different patients
Sex: F
Vaccine: COVID19
Symptoms: Pelvic discomfort
Clinical narrative: My wife and I stay hydrated either before or at least after our second shot so as to help reduce the impact of any side effects; his wife experienced tiredness; discomfort for several days; sore arms; lethargy; she experienced discomfort for both of her buttock; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (BNT162B2), administration date 27Feb2021 (Batch/Lot number: unknown) as 1st dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "My wife and I stay hydrated either before or at least after our second shot so as to help reduce the impact of any side effects"; FATIGUE (non-serious), outcome "unknown", described as "his wife experienced tiredness"; DISCOMFORT (non-serious), outcome "unknown", described as "discomfort for several days"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arms"; LETHARGY (non-serious), outcome "unknown", described as "lethargy"; PELVIC DISCOMFORT (non-serious), outcome "unknown", described as "she experienced discomfort for both of her buttock".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021285186 same reporter/drug/AE, different patients
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: big headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A 72 year-old female patient received bnt162b2 (BNT162B2), administration date 13Mar2021 (Batch/Lot number: unknown) at the age of 72 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset Mar2021, outcome "unknown", described as "big headache".  Additional information: The patient had received Pfizer Covid-19 vaccine first dose 13Mar2021 and experienced a big headache. Wanted to know if patient can take something like Tylenol or Ibuprofen.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Vaccination site discomfort
Clinical narrative: feeling unwell; his right arm where he got the shot is feeling pretty heavy; Chills; Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 19 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 11Mar2021 13:05 (Lot number: L3247) at the age of 19 years as dose 2 , single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose, LOT EL3247), administration date: 18Feb2021, when the patient was 19 years old, for COVID-19 immunisation.  The following information was reported: CHILLS (non-serious) with onset 12Mar2021 01:00, outcome "unknown", described as "Chills"; FATIGUE (non-serious) with onset 12Mar2021 01:00, outcome "unknown", described as "Tiredness"; MALAISE (non-serious) with onset 12Mar2021 05:00, outcome "unknown", described as "feeling unwell"; VACCINATION SITE DISCOMFORT (non-serious) with onset 12Mar2021 05:00, outcome "unknown", described as "his right arm where he got the shot is feeling pretty heavy". Therapeutic measures were not taken as a result of chills, fatigue, malaise, vaccination site discomfort.  Additional information: The patient stated that, through out the day he was exhausted. He stated that it was not too serious, he had got a health care professional that told him it would probably be gone in 48 hours.  No follow-up attempts are possible. No further information is expected.